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Background: Chronic kidney disease (CKD) is an emerging public health problem worldwide. Previous studies have
shown an association between blood pressure (BP) and CKD. However, it is not clear if there are ethnic differences
in this association. We examined the association between BP and CKD in a multi-ethnic Asian population in
Singapore.
Methods: We analysed data from three large population-based studies conducted between 2004–2011, (n=3,167
Chinese, 3,082 Malays and 3,228 Indians) aged 40–80 years. CKD was defined as an estimated glomerular filtration
rate <60 mL/min/1.73m2 from serum creatinine. Hypertension was defined as a self-reported current use of
antihypertensive medication or systolic BP ≥140 mm Hg or diastolic BP ≥90 mm Hg. We also analysed the
association of CKD with individual BP components.
Results: The prevalence of both hypertension and CKD was higher among Malays (68.6, 21%) compared to
Chinese (57.9, 5.9%) and Indians (56.0, 7.4%), but treatment for hypertension was lower among Malays (53.4%)
compared to Chinese (89.8%) and Indians (83.1%). Hypertension was associated with CKD in all three ethnic
groups (OR [95% CI] = 2.71 [1.59-4.63], 2.08 [1.62-2.68], 2.43 [1.66-3.57] in Chinese, Malays and Indians). Among the
BP components, both systolic and diastolic BP were associated with CKD in Malays whereas, systolic BP was
not significantly associated with CKD, and diastolic BP showed an inverse association which was explained by
anti-hypertensive medication use in Chinese and Indians.
Conclusions: Hypertension was associated with CKD in Chinese, Malays and Indians. However, the BP
components were associated with CKD only in Malays.
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Hypertension is an established risk factor for chronic
kidney disease (CKD) associated with increased risk for
progression to renal failure and adverse cardiovascular
outcomes [1-3]. Evidence from clinical trials suggest a
beneficial effect of optimal BP control on CKD progres-
sion [4,5]. Hypertension has been shown to be an im-
portant risk factor for CKD in addition to diabetes in
Western populations [6,7]. Recent studies conducted in* Correspondence: charumathi.sabanayagam@seri.com.sg
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distribution, and reproduction in any mediumthe US have shown that hypertension of all ranges in-
cluding prehypertension [7,8] and all components in-
cluding systolic BP [8-13], diastolic BP [11] and pulse
pressure [13] are associated with CKD. Ethnic minorities
including blacks and Asian Americans [14] were shown
to be at increased risk of developing CKD compared to
whites in the US. The prevalence of both hypertension
and CKD are increasing in Asian populations [15]. It has
also been suggested that the risk factor associations of
CKD are different in Asians compared to whites. For ex-
ample, in the KEEP-2 study in the US involving Asian
Americans, Pacific islanders and whites, while hyperten-
sion was a significant risk factor for CKD in whites,
Japanese, Native Hawaiians, Filipinos, no significantentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Sabanayagam et al. BMC Nephrology 2013, 14:86 Page 2 of 11
http://www.biomedcentral.com/1471-2369/14/86association was observed between hypertension and CKD
in Chinese [16]. Given the ethnic differences in the preva-
lence of both hypertension and CKD [17] in Asian popula-
tions, it is important to clarify the association between BP
and CKD in Asian ethnic groups. However, studies exam-
ining the association between BP and CKD in Asian
populations have shown mixed results. While some
studies involving Malays [18] and Japanese men [19]
have reported an association between BP and CKD, some
studies involving Chinese [20], Japanese [21] and Korean
adults [22] have documented no significant association be-
tween BP and CKD. This inconsistency could partly be
due to differences in methodology or population charac-
teristics. To address this gap in literature, we aimed to
examine the relationship between hypertension, individual
BP components and CKD among Chinese, Malays and
Indians in Singapore. The availability of three large datasets
representing three largest Asian ethnic groups of similar
age group, geographic region and study methods provides a
unique opportunity to study the ethnic differences in the
association between BP and CKD in Asia.
Methods
Study population
We evaluated data obtained from three large cross-
sectional studies, Singapore Chinese Eye Study (SCES),
Singapore Malay Eye Study (SiMES) and the Singapore
Indian Eye Study (SINDI). SiMES, the first of the three
studies was conducted between 2004–2006, followed by
SINDI between 2007–2009 and the SCES between
2009–2011. All three studies followed the same study
protocol and were conducted in the same study clinic
(Singapore Eye Research Institute). All study participants
were recruited from the southwestern part of Singapore.
According to the 2000 Singapore census, the residents
of southwestern part were a fair representation of the
Singapore population in terms of age distribution and
socioeconomic status. Details of the study population
and methods of SiMES have been published elsewhere
[23]. In brief, in SiMES, 5600 individuals were selected
by an age-stratified random sampling method from the
computer generated random list of 16,069 Malay names
based on unique identity card number of the residents
provided by the Ministry of Home Affairs. Of the 4,168
eligible individuals, 3280 participated in the study (78.7%
response rate). Of the 3,148 participants with serum cre-
atinine measurements, after excluding those with missing
information on variables included in the multivariable
model (n=66), 3,082 were included in the final analysis. In
SINDI [24], 6,350 adults were selected by an age-stratified
random sampling method from the computer generated
random list of 11,616 Indian names provided by the Min-
istry of Home Affairs. Of the 4,497 eligible participants,
3,400 participated in the study (75.6% response rate). Ofthe 3,259 participants with serum creatinine measure-
ments, after excluding those with missing information on
variables included in the multivariable model (n=31),
3,228 provided data for the final analysis. In SCES [24],
6,752 adults were selected by an age-stratified random
sampling method from the computer generated random
list of 12,000 Chinese names provided by the Ministry of
Home Affairs. Of the 4,605 eligible participants, 3,353 par-
ticipated in the study (72.8% response rate). Of the 3,192
participants with serum creatinine measurements, after
excluding those with missing information on variables in-
cluded in the multivariable model (n=25), 3,167 provided
data for the final analysis. Written informed consent was
obtained from all participants and all studies were ap-
proved by the Singapore Eye Research Institute Institu-
tional Review Board.
Exposure measurement
Information on participants’ demographic characteristics,
educational attainment, monthly income, cigarette smok-
ing, alcohol consumption and medical history were
obtained using a standardized questionnaire administered
by trained personnel. BP measurement was taken with
a digital automatic blood pressure monitor, (Dinamap
model Pro Series DP110X-RW, 100V2; GE Medical Sys-
tems Information Technologies, Inc., USA) on 2 occasions
5 minutes apart, after the participants were seated for at
least 5 minutes. If the blood pressures differed by more
than 10 mm Hg systolic or 5 mm Hg diastolic, a third
measurement was taken and BP of the individual was
taken as the average of the two closest readings. Hyperten-
sion was defined as systolic BP ≥140 mm Hg or diastolic
BP ≥90 mm Hg or self-reported previously diagnosed
hypertension. BP was also categorized according to the
JNC 7 categories [25] as 1) normal BP (<120 mm Hg sys-
tolic and <80 mm Hg diastolic); 2) prehypertension (120
to 139 mm Hg systolic or 80–89 mm Hg diastolic); 3)
stage 1 hypertension (140 to 159 mm Hg systolic or 90 to
99 mm Hg diastolic); 4) stage 2 hypertension (≥160 mm
Hg systolic or ≥100 mm Hg diastolic). All subjects on
anti-hypertensive medication were classified as hyperten-
sive irrespective of current BP. Thus those on antihyper-
tensive medication but with ‘normal or prehypertensive
range of BP’ were categorized under stage 1 hypertension
and the rest were classified under stage 2 hypertension.
Pulse pressure (PP) was defined as the difference between
systolic BP and diastolic BP.
Measurement of outcome
CKD was defined as an eGFR of <60 mL/min/1.73 m2
based on the US National Kidney Foundation Kidney
Disease Outcome Quality Initiative (NKF-KDOQI)
CKD stage 3 and above. GFR was estimated from serum
creatinine using the recently developed Chronic Kidney
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[26] as follows: 141 × min(Scr/k, 1)
α× max(Scr/k, 1)
-1.209×
0.993Age ×1.018 (for women), where Scr is serum creatin-
ine, k is 0.7 for females and 0.9 for males, α is −0.329
for females and −0.411 for males, min indicates the
minimum of Scr/k or 1, and max indicates the max-
imum of Scr/k or 1. Serum creatinine was measured
using an enzymatic method calibrated to the National
Institute of Standards and Technology (NIST) Liquid
Chromatography Isotope Dilution Mass Spectrometry
(LC-IDMS) method recommended by the National
Kidney Disease Education Program and traceable to NIST
SRM967. Validation studies conducted in Singapore have
shown CKD-EPI to be more accurate than MDRD in par-
ticular at higher eGFRs [27] and the prevalence of CKD
by both MDRD and CKD-EPI to be similar in all three
ethnic groups [28] suggesting the adoption of CKD-EPI
equation without ethnic adjustment [27].
Definition of other variables
Age was defined as the age at the time of examination and
was categorized into 4 groups: 40–49, 50–59, 60–69, and
70–80. Education was used as an indicator of socioeco-
nomic status and was categorized into 1) primary and
below (≤6 years) 2) high school and above (>6 years). In-
come level was defined as individual gross income per
month in Singapore dollars (SGD) and divided in to three
categories: <1000, 1000 to <2000, ≥2000. Body mass index
(BMI) was calculated as weight in kilograms divided by
the square of height in meters (kg/m2). Diabetes mellitus
was defined as a casual plasma glucose ≥200 mg/dl
(11.1 mmol/L) or self-reported physician-diagnosed dia-
betes or use of glucose-lowering medication. Cigarette
smoking was categorized into current, former and never
smoker and alcohol consumption into drinkers and non-
drinkers.
Statistical analysis
We compared selected baseline characteristics of the
study participants among the three ethnic groups using
chi square test or analysis of variance, as appropriate for
the variable. We examined the association of hyperten-
sion and JNC-7 categories of BP with CKD in three sep-
arate logistic regression models. In the first model we
adjusted for age (years) and sex and in the multivariable
model we additionally adjusted for categories of educa-
tion, cigarette smoking, alcohol consumption, diabetes
mellitus, and BMI (kg/m2). In the third model, we ad-
justed for antihypertensive medication use in addition to
variables adjusted in the second model. We then exam-
ined the association of individual BP components (sys-
tolic, diastolic and PP) with CKD in the same regression
models by categorizing BP in to quartiles of systolic BP,
diastolic BP and PP. Since there were large differences inthe distribution of systolic and diastolic BP among the
three ethnic groups (p<0.0001), ethnicity specific quar-
tiles were used for categorizing BP components. For this
analysis, the lowest quartiles of systolic BP, diastolic BP
and PP were used as the reference categories. Tests for
trend were performed using the quartiles of BP as or-
dinal variables in corresponding regression models. We
also analysed each component of BP as a continuous
variable (per 10 units increase). Finally, we calculated
the population attributable risk of CKD associated with
hypertension in each ethnic group using Levin’s formula,
Pe (RR-1)/(1+Pe (RR-1)) where Pe = Prevalence of ex-
posure in the population [29,30]. We performed the ana-
lysis separately for each ethnic group. All statistical
analyses were performed using SAS version 9.1.
Results
Selected baseline characteristics of the three ethnic
groups are shown in Table 1. Of the three ethnic groups,
Chinese were older, less likely to be primary/below edu-
cated, and had lower levels of glucose, HbA1C and BMI
levels and higher levels of eGFR than Malays and In-
dians. Malays were more likely to be primary & below
educated, to have income < SGD 1000, and current
smokers, had higher prevalence of hypertension, and
overweight/obesity, had higher levels of systolic BP, dia-
stolic BP and BMI and lower levels of eGFR and less
likely to use antihypertensive medication; Indians were
more likely to be ever drinkers, had higher prevalence of
diabetes, higher levels of blood glucose, triglycerides and
lower levels of total cholesterol and HDL cholesterol.
The distributions of SBP and DBP by age categories in
the three ethnic groups are shown in Figure 1A and 1B.
Systolic BP increased with age in all three populations;
diastolic BP increased up to 60 years, plateau around 60
years and began to decline after 70 years in Chinese
whereas diastolic BP increased up to 60 years and began
to decline after 60 years in Malays and Indians. Systolic
BP was consistently higher across all age groups in
Malays as compared to Chinese and Indians. A similar
higher trend for diastolic BP was also noted in Malays as
compared to Chinese and Indians. The prevalence of CKD
was highest among Malays (21.0%) followed by Indians
(7.4%) and Chinese (5.9%). Table 2 shows the association
between BP categories and CKD in the Chinese popula-
tion. Majority of those with hypertension belonged to
stage 1 hypertension. The prevalence of CKD increased
with increasing JNC 7 BP categories and a significant
graded association was observed across the JNC-7 BP cat-
egories in the multivariable model (p-trend =0.005).
Among the individual JNC-7 categories, although none of
the categories showed a significant statistical association,
the direction of association with CKD was positive for
stage 1 and 2 hypertension, but was negative for
Table 1 Characteristics of the study participants by study cohort*
Chinese Malay Indian P value†
(n=3,167) (n=3,082) (n=3,228)
Age, mean (SD), years 59.4 (9.8) 58.7 (11.0) 57.5 (10.0) <0.0001
Gender, female, % 50.1 52.0 49.2 0.07
Primary & below education, % 52.5 75.3 55.6 <0.0001
Income <SGD 1000, % 46.1 68.8 48.2 <0.0001
Current smoking, % 13.0 20.2 14.9 <0.0001
Alcohol consumption, % 11.1 1.5 12.9 <0.0001
Hypertension, % 57.9 68.6 56.0 <0.0001
Antihypertensive medication use among those with previously
diagnosed hypertension, %
89.8 53.4 83.1 <0.0001
Overweight/obesity, % 32.1 57.8 56.6 <0.0001
Blood glucose, mmol/L 6.4 (2.8) 6.8 (3.7) 7.2 (3.6) <0.0001
Glycated hemoglobin (HbA1C), % 6.1 (0.9) 6.5 (1.6) 6.4 (1.4) <0.0001
Systolic BP, mean (SD), mm Hg 136.2 (19.2) 147.2 (23.8) 135.2 (19.5) <0.0001
Diastolic BP, mean (SD), mm Hg 77.6 (9.8) 79.8 (11.2) 77.5 (10.1) <0.0001
Total cholesterol, mean (SD), mmol/L 5.5 (1.1) 5.6 (1.2) 5.2 (1.1) <0.0001
HDL-cholesterol, mean (SD), mmol/L 1.3 (0.4) 1.4 (0.3) 1.1 (0.3) <0.0001
Triglycerides, mean (SD), mmol/L 1.8 (1.3) 1.6 (1.3) 2.0 (1.2) <0.0001
Body mass index, mean (SD), kg/m2 23.7 (3.6) 26.4 (5.1) 26.2 (4.8) <0.0001
Estimated GFR, mL/min/1.73 m2 88.9 (18.5) 74.4 (20.4) 87.2 (18.1) <0.0001
Abbreviations: HDL, high-density lipoprotein; GFR, glomerular filtration rate; SD, standard deviation.
* Data presented are row percentages or mean values and corresponding standard error.
†P value represents difference in characteristics by study cohort based on analysis of variance or chi square test as appropriate.
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nificant positive association with CKD. Among the individ-
ual components, systolic BP and PP were not significantly
associated with CKD in both quartile and continuous ana-
lysis. In contrast, diastolic BP was inversely associated with
CKD in both models. However, this inverse association lost
significance when we additionally adjusted for antihyper-
tensive medication use.
Table 3 shows the association between BP categories
and CKD in the Malay population. Majority of those
with hypertension belonged to stage 2 hypertension. A
significant graded association was observed across cat-
egories of JNC with CKD (p-trend <0.0001). ComparedA B
Figure 1 Distribution of systolic BP (1A) and diastolic BP (1B) by ageto those with normal BP, stage 1 and 2 hypertension
showed a significant positive association with CKD.
Prehypertension showed a positive association with CKD
though short of significance. Presence of hypertension
showed a significant positive association with CKD. All
components of BP including systolic BP, diastolic BP and
PP were significantly associated with CKD in both quartile
and continuous analysis. This positive association between
BP components and CKD remained unaltered with
additional adjustment for antihypertensive medication.
Table 4 shows the association between BP categories
and CKD in the Indian population. Majority of those with
hypertension had stage 1 hypertension. A significantgroups across the three ethnic groups.
Table 2 Association between blood pressure (BP) categories and eGFR <60 mL/min/1.73 m2 in Chinese population
BP categories No. at risk
(cases)











Normal 492 (7) 1.4 1.00 (referent) 1.00 (referent) -
Prehypertension 771 (10) 1.3 0.55 (0.20-1.50) 0.49 (0.18-1.35)
Stage1 hypertension 1057 (88) 8.3 2.14 (0.95-4.82) 1.67 (0.73-3.81)
Stage 2 hypertension 847 (115) 13.6 2.29 (1.01-5.18) 1.69 (0.73-3.90)
P trend 0.002 0.005
Hypertensive status
Normotensive 1263 (17) 1.4 1.00 (referent) 1.00 (referent) -
Hypertensive 1904 (203) 10.7 3.27 (1.94-5.53) 2.71 (1.59-4.63)
Systolic BP quartiles
Quartile 1 (82–122 mm Hg) 780 (32) 4.1 1.00 (referent) 1.00 (referent) 1.00 (referent)
Quartile 2 (123–135 mm Hg) 839 (46) 5.5 0.97 (0.59-1.61) 0.91 (0.54-1.52) 0.81 (0.48-1.37)
Quartile 3 (136–147 mm Hg) 754 (60) 8.0 0.89 (0.55-1.46) 0.82 (0.50-1.35) 0.75 (0.45-1.25)
Quartile 4 (148–225 mm Hg) 794 (82) 10.3 0.77 (0.48-1.25) 0.68 (0.42-1.11) 0.64 (0.39-1.07)
P trend 0.2 0.9 0.8
Each 10 units increase in systolic BP 0.96 (0.88-1.04) 0.94 (0.86-1.02) 0.94 (0.86-1.03)
Diastolic BP quartiles
Quartile 1 (50–70 mm Hg) 869 (83) 9.6 1.00 (referent) 1.00 (referent) 1.00 (referent)
Quartile 2 (71–76 mm Hg) 723 (45) 6.2 0.53 (0.35-0.81) 0.55 (0.36-0.84) 0.53 (0.34-0.83)
Quartile 3 (77–83 mm Hg) 774 (54) 7.0 0.72 (0.48-1.07) 0.70 (0.47-1.04) 0.69 (0.44-1.08)
Quartile 4 (84–117 mm Hg) 801 (38) 4.7 0.53 (0.34-0.82) 0.53 (0.34-0.83) 0.63 (0.36-1.09)
P trend 0.01 0.01 0.1
Each 10 units increase in diastolic BP 0.82 (0.69-0.98) 0.81 (0.68-0.97) 0.87 (0.69-1.09)
Pulse pressure quartiles
Quartile 1 (21–46 mm Hg) 786 (23) 2.9 1.00 (Referent) 1.00 (Referent) 1.00 (referent)
Quartile 2 (47–55 mm Hg) 775 (36) 4.7 0.96 (0.54-1.69) 0.90 (0.51-1.61) 0.85 (0.47-1.54)
Quartile 3 (56–67 mm Hg) 800 (59) 7.4 1.03 (0.60-1.77) 0.91 (0.53-1.58) 0.80 (0.45-1.39)
Quartile 4 (68–121 mm hg) 806 (102) 12.7 0.92 (0.53-1.58) 0.80 (0.46-1.39) 0.71 (0.40-1.24)
P trend 0.7 0.4 0.2
Each 10 units increase in pulse pressure 1.00 (0.90-1.10) 0.97 (0.88-1.08) 0.96 (0.87-1.07)
Abbreviations: eGFR, estimated glomerular filtration rate; OR, odds ratio; CI, confidence interval; * Adjusted for age (years), gender, education (primary and below,
high school and above), body mass index (kg/m2), smoking (current, former, never), alcohol intake (present, absent), diabetes status (present, absent).
† Adjusted for variables in model 1 + antihypertensive medication use.
‡ BP classified according to Seventh Report of the Joint National Committee (JNC 7) on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure criteria (normal, systolic BP <120 mm Hg and diastolic BP <80 mm Hg; prehypertension,
systolic BP 120–139 or diastolic BP 80–89 mm Hg; stage 1 hypertension, systolic BP 140–159 or diastolic BP 90–99 mm Hg;
stage 2 hypertension, systolic BP ≥160 or diastolic BP ≥100 mm Hg).
Hypertension was defined as a self-reported current use of antihypertensive medication or systolic BP ≥140 mm Hg or diastolic BP ≥90 mm Hg.
Sabanayagam et al. BMC Nephrology 2013, 14:86 Page 5 of 11
http://www.biomedcentral.com/1471-2369/14/86graded association was observed between JNC-7 categor-
ies and CKD (p-trend = 0.001) and stage 1 and 2 hyper-
tension showed a significant positive association with
CKD. Similar to Chinese, prehypertension showed a non-
significant negative association with CKD. Presence of
hypertension showed a significant positive association with
CKD similar to the other two ethnic groups. Among the
individual components, systolic BP was not significantlyassociated with CKD in both quartile and continuous ana-
lysis. In contrast, diastolic BP was inversely associated with
CKD in both age, sex-adjusted and the first multivariable
model. However, this inverse association lost significance
with additional adjustment to antihypertensive medication
use. Similarly, pulse pressure showed a positive association
with CKD in quartile and continuous analysis in the age,
sex-adjusted and the first multivariable model. But the
Table 3 Association between blood pressure (BP) categories and eGFR <60 mL/min/1.73 m2 in Malay population
BP categories No. at risk
(cases)











Normal 300 (15) 5.0 1.00 (referent) 1.00 (referent) -
Prehypertension 757 (84) 11.1 1.65 (0.92-2.97) 1.55 (0.85-2.81)
Stage1 hypertension 877 (181) 20.6 2.51 (1.43-4.43) 2.25 (1.27-4.01)
Stage 2 hypertension 1148 (406) 35.4 4.19 (2.40-7.32) 3.58 (2.03-6.32)
P trend <0.0001 <0.0001
Hypertensive status
Normotensive 1057 (99) 9.4 1.00 (referent) 1.00 (referent) -
Hypertensive 2025 (587) 29.0 2.26 (1.77-2.90) 2.08 (1.62-2.68)
Systolic BP quartiles
Quartile 1 (84–129 mm Hg) 761 (81) 10.6 1.00 (referent) 1.00 (referent) 1.00 (referent)
Quartile 2 (130–143 mm Hg) 744 (132) 17.7 1.40 (1.02-1.92) 1.29 (0.94-1.79) 1.25 (0.90-1.73)
Quartile 3 (144–162 mm Hg) 7987 (196) 24.6 1.71 (1.26-2.31) 1.53 (1.12-2.09) 1.46 (1.07-2.00)
Quartile 4 (163–275 mm Hg) 7794 (277) 35.6 2.19 (1.63-2.95) 1.97 (1.45-2.66) 1.94 (1.43-2.64)
P trend <0.0001 <0.0001 <0.0001
Each 10 units increase in systolic BP 1.13 (1.09-1.18) 1.11 (1.07-1.16) 1.12 (1.07-1.17)
Diastolic BP quartiles
Quartile 1 (48–70 mm Hg) 727 (152) 20.9 1.00 (referent) 1.00 (referent) 1.00 (referent)
Quartile 2 (71–77 mm Hg) 752 (172) 22.9 1.04 (0.79-1.36) 1.05 (0.80-1.38) 1.06 (0.80-1.39)
Quartile 3 (78–86 mm Hg) 833 (173) 20.8 1.02 (0.78-1.33) 1.00 (0.76-1.32) 1.03 (0.78-1.36)
Quartile 4 (87–131 mm Hg) 770 (189) 24.6 1.27 (0.97-1.66) 1.31 (0.99-1.72) 1.39 (1.05-1.83)
P trend 0.1 0.08 0.03
Each 10 units increase in diastolic BP 1.09 (1.00-1.19) 1.10 (1.01-1.20) 1.13 (1.04-1.23)
Pulse pressure quartiles
Quartile 1 (26–52 mm Hg) 758 (64) 8.4 1.00 (referent) 1.00 (referent) 1.00 (referent)
Quartile 2 (53–65 mm Hg) 781 (130) 16.7 1.47 (1.05-2.07) 1.33 (0.94-1.88) 1.30 (0.91-1.84)
Quartile 3 (66–79 mm Hg) 765 (192) 25.1 1.82 (1.31-2.54) 1.51 (1.07-2.12) 1.45 (1.03-2.04)
Quartile 4 (80–136 mm hg) 778 (300) 38.6 2.58 (1.85-3.61) 2.10 (1.49-2.95) 2.04 (1.44-2.87)
P trend <0.0001 <0.0001 <0.0001
Each 10 units increase in pulse pressure 1.21 (1.14-1.28) 1.17 (1.10-1.24) 1.16 (1.09-1.23)
Abbreviations: eGFR, estimated glomerular filtration rate; OR, odds ratio; CI, confidence interval; * Adjusted for age (years), gender, education (primary and below,
high school and above), body mass index (kg/m2), smoking (current, former, never), alcohol intake (present, absent), diabetes status (present, absent).
† Adjusted for variables in model 1 + antihypertensive medication use.
‡ BP classified according to Seventh Report of the Joint National Committee (JNC 7) on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure criteria (normal, systolic BP <120 mm Hg and diastolic BP <80 mm Hg; prehypertension,
systolic BP 120–139 or diastolic BP 80–89 mm Hg; stage 1 hypertension, systolic BP 140–159 or diastolic BP 90–99 mm Hg;
stage 2 hypertension, systolic BP ≥160 or diastolic BP ≥100 mm Hg).
Hypertension was defined as a self-reported current use of antihypertensive medication or systolic BP ≥140 mm Hg or diastolic BP ≥90 mm Hg.
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ment for antihypertensive medication. In Table 5, we have
summarized the effect estimates of CKD associated with
hypertension and BP components in the three ethnic
groups. In PAR calculations, the proportion of CKD
prevalence that can be attributable to hypertension was
49.8% among Chinese, 42.6% among Malays and 44.4%
among Indians.Discussion
In this study, examining the association between BP and
CKD using data from three independent studies of Chinese,
Malay and Indian ethnic groups aged 40–80 years in
Singapore, we found that although hypertension was associ-
ated with CKD in all three ethnic groups, the pattern of as-
sociation between individual BP components and CKD
varied across ethnic groups. We found that in Malays, all
Table 4 Association between blood pressure (BP) categories and eGFR <60 mL/min/1.73 m2 in Indian population
BP categories No. at risk
(cases)











Normal 532 (12) 2.3 1.00 (referent) 1.00 (referent) -
Prehypertension 834 (24) 2.9 0.98 (0.48-2.00) 0.87 (0.42-1.78)
Stage1 hypertension 1052 (122) 11.6 2.98 (1.60-5.54) 2.40 (1.28-4.51)
Stage 2 hypertension 810 (106) 13.1 2.63 (1.40-4.95) 1.98 (1.04-3.78)
P trend 8.2 <0.0001 0.002
Hypertensive status
Normotensive 1366 (36) 2.6 1.00 (referent) 1.00 (referent) -
Hypertensive 1862 (228) 12.2 2.86 (1.97-4.16) 2.43 (1.66-3.57)
Systolic BP quartiles
Quartile 1 (79–121 mm Hg) 825 (42) 5.1 1.00 (referent) 1.00 (referent) 1.00 (referent)
Quartile 2 (122–133 mm Hg) 782 (64) 8.2 1.19 (0.78-1.82) 1.11 (0.73-1.71) 1.06 (0.69-1.64)
Quartile 3 (134–147 mm Hg) 817 (54) 6.6 0.76 (0.49-1.18) 0.68 (0.44-1.07) 0.61 (0.39-0.96)
Quartile 4 (148–237 mm Hg) 804 (104) 13.0 1.24 (0.83-1.84) 1.06 (0.71-1.59) 0.96 (0.64-1.45)
P trend 0.5 0.9 0.5
Each 10 units increase in systolic BP 1.00 (0.94-1.08) 0.98 (0.91-1.05) 0.97 (0.90-1.04)
Diastolic BP quartiles
Quartile 1 (43–69 mm Hg) 810 (102) 12.6 1.00 (referent) 1.00 (referent) 1.00 (referent)
Quartile 2 (70–76 mm Hg) 803 (72) 9.0 0.69 (0.49-0.96) 0.74 (0.51-1.06) 0.81 (0.56-1.16)
Quartile 3 (77–83 mm Hg) 786 (52) 6.6 0.55 (0.38-0.79) 0.64 (0.42-0.97) 0.78 (0.52-1.17)
Quartile 4 (84–136 mm Hg) 829 (38) 4.6 0.42 (0.28-0.63) 0.54 (0.32-0.90) 0.71 (0.45-1.13)
P trend <0.0001 0.01 0.1
Each 10 units increase in diastolic BP 0.67 (0.58-0.79) 0.71 (0.58-0.88) 0.83 (0.70-1.00)
Pulse pressure quartiles
Quartile 1 (23–45 mm Hg) 804 (23) 2.9 1.00 (Referent) 1.00 (Referent) 1.00 (referent)
Quartile 2 (46–55 mm Hg) 768 (45) 5.9 1.53 (0.89-2.57) 1.42 (0.83-2.42) 1.40 (0.82-2.41)
Quartile 3 (56–67 mm Hg) 846 (72) 8.5 1.62 (0.98-2.68) 1.35 (0.81-2.25) 1.22 (0.72-2.04)
Quartile 4 (68–121 mm hg) 810 (124) 15.3 2.15 (1.31-3.52) 1.66 (1.00-2.76) 1.46 (0.87-2.43)
P trend 0.002 0.07 0.2
Each 10 units increase in pulse pressure 1.15 (1.06-1.25) 1.09 (1.00-1.19) 1.06 (0.97-1.16)
Abbreviations: eGFR, estimated glomerular filtration rate; OR, odds ratio; CI, confidence interval.
* Adjusted for age (years), gender, education (primary and below, high school and above), body mass index (kg/m2), smoking (current, former, never), alcohol
intake (present, absent), diabetes status (present, absent).
† Adjusted for variables in model 1 + antihypertensive medication use.
‡ BP classified according to Seventh Report of the Joint National Committee (JNC 7) on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure criteria (normal, systolic BP <120 mm Hg and diastolic BP <80 mm Hg; prehypertension,
systolic BP 120–139 or diastolic BP 80–89 mm Hg; stage 1 hypertension, systolic BP 140–159 or diastolic BP 90–99 mm Hg;
stage 2 hypertension, systolic BP ≥160 or diastolic BP ≥100 mm Hg).
Hypertension was defined as a self-reported current use of antihypertensive medication or systolic BP ≥140 mm Hg or diastolic BP ≥90 mm Hg.
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were significantly associated with CKD. In Chinese and
Indians, systolic BP and PP did not show a significant asso-
ciation whereas diastolic BP showed an inverse association
with CKD which was explained by anti-hypertensive medi-
cation use in both ethnic groups.
We found that the prevalence of both hypertension and
CKD were higher among Malays compared to Chineseand Indians consistent with a recent report from the
Singapore National Health Survey (NHS) 2010 [31], and
from a cross-sectional study in Malaysia [32]. In addition,
the pattern of distribution of risk factors of CKD across
the three ethnic groups observed in the current study
closely followed that reported by the recent NHS [31]. For
example, the prevalence of current smoking and obes-
ity was higher among Malays and the prevalence of
Table 5 Summary of odds ratio of CKD for BP
components by ethnicity
Ethnic groups Multivariable model 1
OR (95% CI)*
Multivariable model 2
OR (95% CI) †
Hypertension (normotensive Vs. hypertensive)
Chinese 3.27 (1.94-5.53) 2.71 (1.59-4.63)
Malays 2.26 (1.77-2.90) 2.08 (1.62-2.68)
Indians 2.86 (1.97-4.16) 2.43 (1.66-3.57)
Systolic BP (Q4 Vs. Q1)
Chinese 0.68 (0.42-1.11) 0.64 (0.39-1.07)
Malays 1.97 (1.45-2.66) 1.94 (1.43-2.64)
Indians 1.06 (0.71-1.59) 0.96 (0.64-1.45)
Diastolic BP (Q4 Vs. Q1)
Chinese 0.53 (0.34-0.83) 0.63 (0.36-1.09)
Malays 1.31 (0.99-1.72) 1.39 (1.05-1.83)
Indians 0.54 (0.32-0.90) 0.71 (0.45-1.13)
Abbreviations: BP, blood pressure; CI, confidence interval; OR, odds ratio;
Q, quartile.
* Adjusted for age, gender, education, body mass index, smoking, alcohol
intake, diabetes.
† Adjusted for variables in model 1 + antihypertensive medication use.
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http://www.biomedcentral.com/1471-2369/14/86diabetes was higher and levels of HDL cholesterol were
lower among Indians. These consistent findings with pre-
vious reports suggest that our results have sufficient
internal validity.
In the current study, presence of hypertension was asso-
ciated with CKD in all three ethnic groups with the PAR
of hypertension being 49.8%, 42.6% and 44.4% in Chinese,
Malays and Indians. Hypertension has consistently been
shown to be an important risk factor for CKD in Western
populations [7,8,13,33]. While majority of the studies in-
volving Asian populations [19,34-36] have reported an as-
sociation between hypertension and CKD, few studies
involving Asian Chinese in the US [16], a large cohort of
adults in Japan [21] and Korea [22] have documented
no significant association of hypertension with CKD.
Although hypertension has been shown to be an import-
ant risk factor for ESRD in the US general population, eth-
nic differences have been reported in the association
between hypertension and ESRD with blacks having a 4–5
fold increased risk of hypertensive ESRD compared to
whites [37,38]. However, in the current study, the magni-
tude of association between hypertension and CKD was
similar (OR ranging from 2.08 to 2.71) across the three
ethnic groups. In addition to hypertension categories,
studies conducted in the Western populations reported a
positive association between prehypertension and CKD
[8,39-41]. Consistent with previous reports, in the current
study, a weak positive association was found between
prehypertension and CKD only in Malays.
In the current study, systolic BP was associated with
CKD only in Malays. Of all the BP components, systolicBP has been shown to be the most useful predictor of
CKD in both general [3,10,12,13] as well as high-risk pop-
ulations [42]. Further, systolic BP predicts progression of
CKD [9,43,44] and adverse outcomes [45,46] among those
with pre-existing CKD. Systolic BP was shown to be a sig-
nificant predictor of CKD among male Physicians in the
Physicians Health Study (PHS) [13], in a large cohort of
men in the MRFIT study [10] and in an elderly cohort with
isolated systolic hypertension in the US [12]. Two reviews
of observational epidemiological studies and clinical trials
reported a graded association between systolic BP and
CKD and a reduced risk of CKD with systolic BP reduction
[3,46]. In the Kidney Disease Early Evaluation Program
(KEEP) involving African Americans at-risk for CKD, sys-
tolic BP was associated with both early and late stages of
CKD [42]. Systolic BP has also been shown to be associated
with progression of CKD in a small cohort of male veterans
[9], a large cohort of KEEP participants [11], and in a large
cohort of adults in the REasons for the Geographic And
Racial Differences in Stroke study [43] with preexisting
CKD. While studies involving Western populations have
shown a consistent positive association between systolic BP
and CKD, the pattern of association of systolic BP with
CKD has not been consistent in Asian populations. Systolic
BP was shown to be strong predictor of ESRD in a large
cohort of Chinese adults who participated in the China
National Hypertension Survey Epidemiology Follow-up
Study (CHEFS) [44] and in a large cohort of middle-aged
Japanese men who participated in the Kansai Healthcare
Study in Japan [19]. However, similar to our findings in
Chinese and Indians, three cross-sectional studies involv-
ing Chinese [20], and Japanese [21,47] adults reported no
significant association between systolic BP and CKD.
We found that elevated levels of diastolic BP were asso-
ciated with CKD in Malays only. Compared to systolic BP,
diastolic BP has been shown to be less predictive of CKD
and adverse outcomes in CKD in majority of the studies
conducted in Western populations [9,13,43,48]. In the
PHS, of all the BP components, diastolic BP was found to
be less predictive of CKD [13]. In the Reduction in end-
points in NIDDM with the Angiotensin II Antagonist
Losartan (RENAAL) Study, an increased risk for ESRD
was observed for systolic BP only [48]. Similar results were
observed in a prospective study of veterans with CKD by
Agarwal et al. in the US [9]. In the REGARDS, for a 11
mm increased in diastolic BP, the risk of ESRD increased
by 38% [43], however, when systolic and diastolic BP were
considered together, the association of diastolic BP with
ESRD lost significance [43]. In the KEEP study, diastolic
BP greater than 90 mm Hg was associated with an in-
creased risk for ESRD in subjects with CKD [11]. Similar
to our findings in Malays, majority of the studies involving
Asian populations have shown an association between dia-
stolic BP and CKD [19,21,49] and ESRD [44,50]. Diastolic
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of Koreans [49], and two cohorts of Japanese [19,21]. Simi-
lar association between diastolic BP and ESRD was ob-
served in a large cohort of Japanese [50] Chinese adults
[44]. In the current study, elevated diastolic BP showed an
inverse association with CKD, in other words, low dia-
stolic BP was associated with CKD in Chinese and Indians.
Although this protective association lost its statistical sig-
nificance after additional adjustment for antihypertensive
medication use in Chinese, and Indians, the direction of
association still remained the same. The reason for the
protective association of diastolic BP with CKD Chinese,
and Indians is not clear. Recent studies have shown that
among those with higher systolic BP, lower diastolic BP,
otherwise wider pulse pressure indicating large arterial
stiffening increases the risk of CVD [51,52]. Accordingly,
when we explored the relationship between systolic and
diastolic BP among the study participants, we found that
76% of Chinese, 86% of Malays and 71% of Indians had
systolic BP ≥130 mm Hg; 21% of Chinese and Indians and
29% of Malays had diastolic BP ≥85 mm Hg; in all three
ethnic groups, over 90% of those with higher diastolic BP
had higher systolic BP. Hence it is conceivable that higher
diastolic BP present among majority of participants with
higher systolic BP is protective against CKD. Tozawa et al.
has shown that use of antihypertensive medication corre-
lated positively with wider PP in hemodialysis patients
[36]. Peralta et al. have shown that treatment of hyperten-
sion with multiple anti-hypertensive drugs is associated
with lowering of diastolic BP more than systolic BP among
CKD subjects [53]. Low diastolic BP in dialysis patients
has been shown to be associated with poorer outcomes
[54]. In the Framingham Heart Study, lower diastolic BP
at any level of systolic BP above 120 mm Hg increased
the risk of coronary heart disease in middle aged and
elderly adults [55]. In a small cohort of male veterans
with CKD in the US, Agarwal et al. has shown an in-
verse association between diastolic BP and all-cause
mortality [9].
In the current study, PP was associated with CKD in
Malays only. The initial association of PP with CKD lost
significance after adjusting for anti-hypertensive medica-
tion use in Indians. PP, a measure of arterial stiffness has
been shown to be associated with CKD [13], and pro-
gression of CKD including ESRD in several studies
[11,43,48,56]. Higher PP and low diastolic BP has been
shown to be associated adverse cardiovascular outcomes
in the Framingham Heart Study [55].
In the current study, Malays had higher levels of systolic
and diastolic BP at all age groups and higher prevalence of
CKD than Chinese and Indians. While hypertension was
positively associated with CKD in all three ethnic groups,
BP components including systolic BP, diastolic BP and PP
were positively associated with CKD only in Malays. InChinese and Indians, while systolic BP and PP did not
show a significant association, diastolic BP showed an
inverse association with CKD that could possibly be
explained by the higher proportion of antihypertensive
medication use in Chinese and Indians. It is possible that
a higher prevalence of underlying risk factors for both
hypertension and CKD may have influenced the positive
association of BP with CKD in Malays. Although Malays
and Indians both had similar adverse metabolic risk profile
(lipids, diabetes and obesity) compared to Chinese, Indians
had lower prevalence of CKD. This is consistent with a
previous study in Singapore that reported Malay ethnicity
to be associated with a higher prevalence of proteinuria
[57] and also consistent with reports from India that
showed a lower prevalence of diabetic retinopathy [58]
and nephropathy [59] among Indians suggesting that
Indians may be less susceptible to microvascular compli-
cations [58,59]. In addition, socioeconomic differentials
across the three ethnic groups contributing to poor BP
control despite treatment [60], and obesity [61] may have
also influenced the association of BP with CKD.
Our study has some limitations. First, because of the
cross-sectional analysis, the temporal association be-
tween BP and CKD could not be elucidated and reverse
causality is possible. Second, we did not examine the ef-
fect of the type of antihypertensive medication in the as-
sociation between BP and CKD as the information on
the type of medication was incomplete. Third, our as-
sessment of BP on a single occasion could have caused a
non-differential misclassification of BP status. Fourth,
we did not have information on microalbuminuria, an-
other indicator of CKD, which is also associated with
diabetes and hypertension. Therefore, we were not able
to study the impact of BP on microalbuminuria. Finally,
while response rates of those invited to participate in the
three studies were excellent (73%-79%), not all subjects
had the necessary data available for the current analysis.
Given the differences in baseline characteristics such as
education level between ethnic groups, it is possible for
non-participation or missing data to introduce a selec-
tion bias. However, the consistency of our findings on
risk factor profile of the three ethnic groups with previ-
ously published reports suggests that this bias is less likely
to influence our findings. The large sample size and the
availability of three independent studies representing three
major Asian ethnic groups with similar methodology and
objective assessment of exposure and outcome measure-
ments are the strengths of our study.
Conclusion
In conclusion, in a large sample of Asian adults repre-
senting three major ethnic groups, we found that the
pattern of association of BP components with CKD
was different across the three ethnic groups. All three
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PP were associated with CKD in Malays. In Chinese and
Indians, systolic BP was not associated with CKD while
diastolic BP showed an inverse association that was
explained by antihypertensive medication use. Our find-
ings in Chinese and Indians may have implications for
anti-hypertensive treatment in CKD patients if confirmed
by future prospective studies.
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